Replies to post #293204 on Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

here are but a few

Clivoten
Italfarmaco, Italy
Dilatol
Jaba, Portugal
DynaCirc
Novartis, Hong Kong; Novartis, Turkey; Novartis AH, South Africa
DynaCirc CR
Reliant, United States
DynaCirc SRO
Novartis, New Zealand; Novartis, Taiwan
Esradin
Sigma-Tau Industrie Farmaceutiche Riunite, Italy
Icaz
Daiichi Sankyo, Tunisia
Icaz LP
Daiichi Sankyo, France
Isradipine Actavis
Actavis, United States
Lomir
Daiichi Sankyo, Belgium; Daiichi-Sankyo, Portugal; Novartis, Bangladesh; Novartis, Bahrain; Novartis, Brazil; Novartis, Czech Republic; Novartis, Finland; Novartis, Greece; Novartis, Hungary; Novartis, Lebanon; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Sweden; Novartis, Slovakia
Lomir Retard
Daiichi Sankyo, Belgium; Novartis, Denmark; Novartis, Iceland
Lomir SRO
2care4, Norway; Daiichi Sankyo, Switzerland; Daiichi Sankyo, Italy; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; Medcor, Netherlands; Novartis, Czech Republic; Novartis, Hungary; Novartis, Netherlands; Novartis, Norway; Novartis, Finland; Novartis, Sweden; Novartis, Poland
Prescal
Novartis Pharmaceuticals UK, United Kingdom
Vascal uno
Sanol, Germany; UCB Pharma, Germany
Vascal uno mite
Sanol, Germany; UCB Pharma, Germany

[NASDAQ2020]

Does getting a new patent for Reformulated SequestOx extend Elite’s exclusivity for that product.?
TIA